Diagnostic and management of high-risk acute myeloblastic leukemia in adult patients

Consulta il libro - Diagnostic and management of high-risk acute myeloblastic leukemia in adult patients

Titolo	Diagnostic and management of high-risk acute myeloblastic leukemia in adult patients
Autori	Roberto M. Lemoli, Adriano Venditti
argomenti	Medicina Oncologia Ematoncologia Medicina Ematologia Leucemie/linfomi
Editore	Minerva Medica
Formato	Libro
Pagine	216
Pubblicazione	2023
ISBN	9788855321938
	Acquistabile con Carta del docente, Carta Cultura Giovani o Carta della Cultura

aggiungi ai desideri

24,00 € 22,80 € (-5%)

aggiungi ai desideri

Disponibile normalmente in 3/4 giorni

Descrizione

High-risk acute myeloblastic leukemia (HR AML) is characterized by unfavorable biologic and clinical features impairing the efficacy of conventional treatments resulting in less than 40% short-term complete remission (CR) rate and poor median overall survival (OS). In addition, high-risk disease occurs, often, in elderly patients with high comorbidity burden and these findings induce poor tolerability to chemotherapy and reduced eligibility to allogeneic stem cell transplantation (HSCT), the only curative therapeutic option in this setting. Here, leading experts in the field cover all the novel aspects concerning the updated definition, the diagnosis, the management and future perspectives tor HR AML patients. Over the last decade the great progress in molecular and cell biology, medicinal chemistry far drug design and immunology have resulted in the development and approval of a large number of novel therapeutics for patients with AML. Although the definition of HR AML is evolving, the better understanding of the genetic and biological characteristics of leukemic cells and their microenviroment will significantly contribute towards novel therapeutic approaches.